Skip to main content
Sirio Pharma Co., Ltd. logo

Sirio Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 300791 ISIN · CNE100003NB0 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,174 across all filing types
Latest filing 2026-03-24 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300791

About Sirio Pharma Co., Ltd.

https://www.siriopharma.com

Sirio Pharma Co., Ltd. is a global contract development and manufacturing organization (CDMO) specializing in dietary supplements and nutraceuticals. The company provides comprehensive services encompassing product formulation, manufacturing, and packaging. Its portfolio includes diverse delivery formats such as softgels, gummies, tablets, hard capsules, powders, and oral liquids. Sirio Pharma emphasizes innovation in delivery systems, offering specialized solutions like plant-based softgels and advanced probiotic formulations. The organization adheres to rigorous quality management systems and maintains multiple international certifications to meet global regulatory standards. Serving an international clientele, the company supports health and wellness brands through scalable production capacities and integrated supply chain solutions.

Recent filings

Filing Released Lang Actions
广东信达律师事务所关于仙乐健康科技股份有限公司2026年限制性股票激励计划首次授予相关事项的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the company's 2026 restricted stock incentive plan's first grant. It references specific legal and regulatory frameworks such as the Company Law, Securities Law, and stock exchange rules. The document details the authorization, approval, grant date, grant price, quantity, and conditions of the stock incentive plan. It is a formal legal opinion rather than a financial report, earnings release, or management discussion. It does not contain financial statements or earnings data but focuses on legal compliance and authorization of a stock incentive plan. This type of document is best classified under Regulatory Filings (RNS) as it is a compliance/legal opinion related to corporate governance and securities regulation, not a financial report or announcement of voting results or capital changes.
2026-03-24 Chinese
2026-035 关于仙乐转债回售的第一次提示性公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the conditional put (回售) of convertible bonds (仙乐转债) issued by the company 仙乐健康科技股份有限公司. It includes specific dates, prices, procedures, and regulatory references related to the bond repurchase event. The content is focused on informing bondholders about the terms and process of exercising their put rights, including risk warnings and tax implications. It is not a financial report, earnings release, or management discussion, nor is it a regulatory certification or a brief announcement of a report publication. The document is a formal announcement about a capital/financing event related to convertible bonds, specifically a bond repurchase (回售) notice. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is 3280 characters, which is consistent with a detailed announcement rather than a full report.
2026-03-24 Chinese
2026年限制性股票激励计划首次授予激励对象名单（授予日）
Remuneration Information Classification · 95% confidence The document is titled as a 2026 Restricted Stock Incentive Plan with a list of initial grant recipients and their allocations. It details the names and positions of management and core technical personnel receiving stock incentives. There is no financial performance data, no mention of annual or quarterly results, no audit information, no voting results, no legal proceedings, no capital raising, and no conference call transcript. The content focuses on the allocation of restricted stock to management and key personnel, which is related to remuneration and incentive plans. This fits best under Remuneration Information (DEF 14A), which covers compensation and incentive plans for executives and directors. The document length is short (2093 characters), and it is not an announcement of a report but the actual incentive plan details. Therefore, the classification is DEF 14A with high confidence.
2026-03-24 Chinese
关于公司股东、董事、副总经理部分股份质押延期购回的公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement regarding the extension of a stock pledge repurchase by a shareholder who is also a director and vice general manager. It details the number of shares pledged, the extension period, and assurances about the shareholder's financial status and the absence of risks to company operations. The document is short (1800 characters) and focuses on a specific share pledge event rather than financial results or management changes. It does not contain financial statements or detailed financial analysis. This fits the category of a Transaction in Own Shares (POS), as it reports on the pledge and repurchase of company shares by insiders.
2026-03-19 Chinese
2026-030 关于公司证券事务代表辞职的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the resignation of the company's securities affairs representative. It does not contain financial data, audit information, or detailed management discussion. It is a regulatory announcement about a change in a company officer related to securities affairs, which fits best under general regulatory filings. The document length is only 513 characters, indicating it is a brief announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2026-03-02 Chinese
第四届董事会第十九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 19th meeting of the 4th Board of Directors of the company. It details the meeting date, attendance, the agenda item about not adjusting the convertible bond conversion price downward, and the voting results. It is not a full report but a meeting resolution announcement. This fits the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board. The document length is short and focused on board decisions, not financial results or other report types.
2026-03-02 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.